ARTICLE | Company News
PerkinElmer, Tissue Regeneration Therapeutics Inc. deal
November 7, 2011 8:00 AM UTC
Tissue Regeneration granted PerkinElmer's ViaCord cord blood banking business an exclusive U.S. license to human umbilical cord perivascular cell (HUCPVC) technology. The technology is used to extract stem cells from the tissue surrounding the vessels of the umbilical cord. ...